| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-18 | 2009-09-30 | 13F-HR/A | Adage Capital Partners Gp Llc | Institution | 2,142,821 | No Change | 0 | 0 % | $85,841,409 | $85,305,704 | $-535,705 | -0.62 % | $0 | | | | | | News Article | History of Adage Capital Partners Gp Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Amvescap Plc | Institution | 585,557 | Sold Some | -1,051 | -0.17 % | $24,031,259 | $23,311,024 | $-720,235 | -2.99 % | $1,293 | | | | | | News Article | History of Amvescap Plc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Credit Suisse First Boston | Institution | 10,618 | Sold Some | -20,279 | -65.63 % | $435,763 | $422,703 | $-13,060 | -2.99 % | $24,943 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Janus Capital Management Llc | Institution | 379,186 | Sold Some | -13,765 | -3.50 % | $15,561,793 | $15,095,395 | $-466,399 | -2.99 % | $16,931 | | | | | | News Article | History of Janus Capital Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Lucrum Capital Llc | Institution | | Sold All | -7,000 | -100 % | | | | -2.99 % | $8,610 | | | | | | News Article | History of Lucrum Capital Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Wells Fargo And Co | Institution | 232,216 | Added More | 11,173 | 5.05 % | $9,530,145 | $9,244,519 | $-285,626 | -2.99 % | $-13,743 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ah Lisanti Capital Growth Llc | Institution | | Sold All | -42,080 | -100 % | | | | -5.03 % | $88,789 | | | | | | News Article | History of Ah Lisanti Capital Growth Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | American International Group Inc | Institution | 13,784 | No Change | 0 | 0 % | $577,825 | $548,741 | $-29,084 | -5.03 % | $0 | | | | | | News Article | History of American International Group Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Aqr Capital Management Llc | Institution | 9,241 | New Holding | 9,241 | 100 % | $387,383 | $367,884 | $-19,499 | -5.03 % | $-19,499 | | | | | | News Article | History of Aqr Capital Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Argus Management Llc | Institution | | Sold All | -25,000 | -100 % | | | | -5.03 % | $52,750 | | | | | | News Article | History of Argus Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ashfield Capital Partners Llc | Institution | 500 | No Change | 0 | 0 % | $20,960 | $19,905 | $-1,055 | -5.03 % | $0 | | | | | | News Article | History of Ashfield Capital Partners Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bam Management Llc | No Data | 46,062 | Sold Some | -31,488 | -40.60 % | $1,930,919 | $1,833,728 | $-97,191 | -5.03 % | $66,440 | | | | | | News Article | History of Bam Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bam Offshore Management Llc | No Data | | Sold All | -70,708 | -100 % | | | | -5.03 % | $149,194 | | | | | | News Article | History of Bam Offshore Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Black River Asset Management Llc | Institution | 2,600 | Added More | 900 | 52.94 % | $108,992 | $103,506 | $-5,486 | -5.03 % | $-1,899 | | | | | | News Article | History of Black River Asset Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Brookside Capital Management Llc | Institution | 19,945 | Sold Some | -688,420 | -97.18 % | $836,094 | $794,010 | $-42,084 | -5.03 % | $1,452,566 | | | | | | News Article | History of Brookside Capital Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Capital World Investors | Institution | 400,000 | No Change | 0 | 0 % | $16,768,000 | $15,924,000 | $-844,000 | -5.03 % | $0 | | | | | | News Article | History of Capital World Investors Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Citadel L P | Institution | 177,553 | Added More | 93,974 | 112.43 % | $7,443,022 | $7,068,385 | $-374,637 | -5.03 % | $-198,285 | | | | | | News Article | History of Citadel L P Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Cobalt Capital Management Inc | Institution | 308,158 | Added More | 72,149 | 30.57 % | $12,917,983 | $12,267,770 | $-650,213 | -5.03 % | $-152,234 | | | | | | News Article | History of Cobalt Capital Management Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Cr Intrinsic Investors Llc | Institution | | Sold All | -140,000 | -100 % | | | | -5.03 % | $295,400 | | | | | | News Article | History of Cr Intrinsic Investors Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Driehaus Capital Management Llc | Institution | | Sold All | -60,276 | -100 % | | | | -5.03 % | $127,182 | | | | | | News Article | History of Driehaus Capital Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Dsc Advisors L P | Institution | 846,900 | Added More | 300,000 | 54.85 % | $35,502,048 | $33,715,089 | $-1,786,959 | -5.03 % | $-633,000 | | | | | | News Article | History of Dsc Advisors L P Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fidelity International Ltd | Institution | | Sold All | -650 | -100 % | | | | -5.03 % | $1,372 | | | | | | News Article | History of Fidelity International Ltd Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fmr Corp | Institution | 1,100,395 | Sold Some | -24,453 | -2.17 % | $46,128,558 | $43,806,725 | $-2,321,833 | -5.03 % | $51,596 | | | | | | News Article | History of Fmr Corp Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fort Hill Capital Management Llc | No Data | | Sold All | -9,490 | -100 % | | | | -5.03 % | $20,024 | | | | | | News Article | History of Fort Hill Capital Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ing Groep Nv | Institution | 96,037 | Added More | 18,315 | 23.56 % | $4,025,871 | $3,823,233 | $-202,638 | -5.03 % | $-38,645 | | | | | | News Article | History of Ing Groep Nv Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Jay Jeffrey R | Institution | 150 | Sold Some | -130,000 | -99.88 % | $6,288 | $5,972 | $-317 | -5.03 % | $274,300 | | | | | | News Article | History of Jay Jeffrey R Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Jesaga Advisers Llc | Institution | 36,000 | Sold Some | -110,400 | -75.40 % | $1,509,120 | $1,433,160 | $-75,960 | -5.03 % | $232,944 | | | | | | News Article | History of Jesaga Advisers Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Loomis Sayles And Co L P | Institution | 55,030 | New Holding | 55,030 | 100 % | $2,306,858 | $2,190,744 | $-116,113 | -5.03 % | $-116,113 | | | | | | News Article | History of Loomis Sayles And Co L P Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Morgan Stanley | Institution | 221,475 | Added More | 74,081 | 50.26 % | $9,284,232 | $8,816,920 | $-467,312 | -5.03 % | $-156,311 | | | | | | News Article | History of Morgan Stanley Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Co Of Connecticut | Institution | | Sold All | -12,630 | -100 % | | | | -5.03 % | $26,649 | | | | | | News Article | History of Northern Trust Co Of Connecticut Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 212,752 | Added More | 10,957 | 5.42 % | $8,918,564 | $8,469,657 | $-448,907 | -5.03 % | $-23,119 | | | | | | News Article | History of Northern Trust Corp Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Oppenheimer Funds Inc | Institution | 278,682 | Added More | 245,118 | 730.30 % | $11,682,349 | $11,094,330 | $-588,019 | -5.03 % | $-517,199 | | | | | | News Article | History of Oppenheimer Funds Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | P Schoenfeld Asset Management Llc | Institution | | Sold All | -236,189 | -100 % | | | | -5.03 % | $498,359 | | | | | | News Article | History of P Schoenfeld Asset Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Palo Alto Investors Llc | Institution | 983,004 | Added More | 189,750 | 23.92 % | $41,207,528 | $39,133,389 | $-2,074,138 | -5.03 % | $-400,373 | | | | | | News Article | History of Palo Alto Investors Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Passport Management Llc | Institution | 166,700 | New Holding | 166,700 | 100 % | $6,988,064 | $6,636,327 | $-351,737 | -5.03 % | $-351,737 | | | | | | News Article | History of Passport Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Perceptive Advisors Llc | Institution | 550,000 | Added More | 532,354 | 3016.85 % | $23,056,000 | $21,895,500 | $-1,160,500 | -5.03 % | $-1,123,267 | | | | | | News Article | History of Perceptive Advisors Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Qvt Financial Lp | Institution | 1,082,601 | Sold Some | -116,170 | -9.69 % | $45,382,634 | $43,098,346 | $-2,284,288 | -5.03 % | $245,119 | | | | | | News Article | History of Qvt Financial Lp Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Rafferty Asset Management Llc | Institution | 4,979 | Sold Some | -2,397 | -32.49 % | $208,720 | $198,214 | $-10,506 | -5.03 % | $5,058 | | | | | | News Article | History of Rafferty Asset Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Sac Capital Advisors Lp | No Data | 637,500 | Added More | 227,500 | 55.48 % | $26,724,000 | $25,378,875 | $-1,345,125 | -5.03 % | $-480,025 | | | | | | News Article | History of Sac Capital Advisors Lp Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Shaw D E And Co Inc | Institution | | Sold All | -4,888 | -100 % | | | | -5.03 % | $10,314 | | | | | | News Article | History of Shaw D E And Co Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Sigma Capital Management Llc | Institution | 10,000 | Sold Some | -62,000 | -86.11 % | $419,200 | $398,100 | $-21,100 | -5.03 % | $130,820 | | | | | | News Article | History of Sigma Capital Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Two Sigma Investments Llc | Institution | | Sold All | -19,463 | -100 % | | | | -5.03 % | $41,067 | | | | | | News Article | History of Two Sigma Investments Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Us Bancorp De | Institution | 1,247 | Added More | 1,039 | 499.51 % | $52,274 | $49,643 | $-2,631 | -5.03 % | $-2,192 | | | | | | News Article | History of Us Bancorp De Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Visium Asset Management Llc | Institution | | Sold All | -100,000 | -100 % | | | | -5.03 % | $211,000 | | | | | | News Article | History of Visium Asset Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wellington Management Co Llp | Institution | 304,600 | Sold Some | -9,400 | -2.99 % | $12,768,832 | $12,126,126 | $-642,706 | -5.03 % | $19,834 | | | | | | News Article | History of Wellington Management Co Llp Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Winslow Management Company Llc | Institution | | Sold All | -243,827 | -100 % | | | | -5.03 % | $514,475 | | | | | | News Article | History of Winslow Management Company Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Am Investment Partners Llc | Institution | | Sold All | -75,500 | -100 % | | | | -6.19 % | $198,565 | | | | | | News Article | History of Am Investment Partners Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ameriprise Financial Inc | Institution | 110,115 | Added More | 109,500 | 17804.87 % | $4,673,281 | $4,383,678 | $-289,602 | -6.19 % | $-287,985 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Arbor Capital Management Llc | Institution | 129,200 | New Holding | 129,200 | 100 % | $5,483,248 | $5,143,452 | $-339,796 | -6.19 % | $-339,796 | | | | | | News Article | History of Arbor Capital Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Artisan Partners Ltd Partnership | Institution | 170,300 | New Holding | 170,300 | 100 % | $7,227,532 | $6,779,643 | $-447,889 | -6.19 % | $-447,889 | | | | | | News Article | History of Artisan Partners Ltd Partnership Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Axa | Institution | 506,958 | Added More | 123,693 | 32.27 % | $21,515,298 | $20,181,998 | $-1,333,300 | -6.19 % | $-325,313 | | | | | | News Article | History of Axa Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barclays Plc | Institution | 100 | Sold Some | -79,555 | -99.87 % | $4,244 | $3,981 | $-263 | -6.19 % | $209,230 | | | | | | News Article | History of Barclays Plc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bnp Paribas Arbitrage Sa | Institution | 6,772 | New Holding | 6,772 | 100 % | $287,404 | $269,593 | $-17,810 | -6.19 % | $-17,810 | | | | | | News Article | History of Bnp Paribas Arbitrage Sa Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Credit Agricole S A | Institution | | Sold All | -4,893 | -100 % | | | | -6.19 % | $12,869 | | | | | | News Article | History of Credit Agricole S A Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Delaware Management Business Trust | Institution | 6,000 | New Holding | 6,000 | 100 % | $254,640 | $238,860 | $-15,780 | -6.19 % | $-15,780 | | | | | | News Article | History of Delaware Management Business Trust Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Denver Investment Advisors Llc | Institution | | Sold All | -105,300 | -100 % | | | | -6.19 % | $276,939 | | | | | | News Article | History of Denver Investment Advisors Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Diamondback Capital Management Llc | Institution | 112,916 | Added More | 36,947 | 48.63 % | $4,792,155 | $4,495,186 | $-296,969 | -6.19 % | $-97,171 | | | | | | News Article | History of Diamondback Capital Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Gartmore Mutual Fund Capital Trust | Institution | 759 | Sold Some | -32,291 | -97.70 % | $32,212 | $30,216 | $-1,996 | -6.19 % | $84,925 | | | | | | News Article | History of Gartmore Mutual Fund Capital Trust Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geode Capital Management Llc | Institution | 43,917 | Added More | 1,220 | 2.85 % | $1,863,837 | $1,748,336 | $-115,502 | -6.19 % | $-3,209 | | | | | | News Article | History of Geode Capital Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 178,791 | Sold Some | -131,823 | -42.43 % | $7,587,890 | $7,117,670 | $-470,220 | -6.19 % | $346,694 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Hambrecht And Quist Capital Management Llc | Institution | 56,000 | New Holding | 56,000 | 100 % | $2,376,640 | $2,229,360 | $-147,280 | -6.19 % | $-147,280 | | | | | | News Article | History of Hambrecht And Quist Capital Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Jefferies Group Inc | Institution | 30,900 | Added More | 23,200 | 301.29 % | $1,311,396 | $1,230,129 | $-81,267 | -6.19 % | $-61,016 | | | | | | News Article | History of Jefferies Group Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Jennison Associates Llc | Institution | 685,200 | No Change | 0 | 0 % | $29,079,888 | $27,277,812 | $-1,802,076 | -6.19 % | $0 | | | | | | News Article | History of Jennison Associates Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Knight Capital Group Inc | Institution | | Sold All | -5,394 | -100 % | | | | -6.19 % | $14,186 | | | | | | News Article | History of Knight Capital Group Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Labranche And Co Inc | Institution | 4,610 | Sold Some | -4,335 | -48.46 % | $195,648 | $183,524 | $-12,124 | -6.19 % | $11,401 | | | | | | News Article | History of Labranche And Co Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Legg Mason Investment Counsel Llc | Institution | 100 | No Change | 0 | 0 % | $4,244 | $3,981 | $-263 | -6.19 % | $0 | | | | | | News Article | History of Legg Mason Investment Counsel Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Marshall Ilsley Corp | Institution | | Sold All | -27,614 | -100 % | | | | -6.19 % | $72,625 | | | | | | News Article | History of Marshall Ilsley Corp Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | N-Q | Met Investors Series Trust - Metaim Small Cap Growth Portfolio | Small-Cap Growth | 153,681 | Added More | 3,932 | 2.62 % | $6,522,222 | $6,118,041 | $-404,181 | -6.19 % | $-10,341 | | | | | | News Article | History of Met Investors Series Trust - Metaim Small Cap Growth Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR/A | Neuberger Berman Group Llc | No Data | | Sold All | -134,900 | -100 % | | | | -6.19 % | $354,787 | | | | | | News Article | History of Neuberger Berman Group Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | New York State Common Retirement Fund | Institution | 800 | Sold Some | -500 | -38.46 % | $33,952 | $31,848 | $-2,104 | -6.19 % | $1,315 | | | | | | News Article | History of New York State Common Retirement Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Paradigm Asset Management Co Llc | Institution | 22,900 | Sold Some | -18,800 | -45.08 % | $971,876 | $911,649 | $-60,227 | -6.19 % | $49,444 | | | | | | News Article | History of Paradigm Asset Management Co Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Pike Place Capital Management Llc | Institution | 14,000 | New Holding | 14,000 | 100 % | $594,160 | $557,340 | $-36,820 | -6.19 % | $-36,820 | | | | | | News Article | History of Pike Place Capital Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Prescott Group Capital Management Llc | Institution | | Sold All | -70,000 | -100 % | | | | -6.19 % | $184,100 | | | | | | News Article | History of Prescott Group Capital Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Price T Rowe Associates Inc | Institution | 42,600 | Sold Some | -35,600 | -45.52 % | $1,807,944 | $1,695,906 | $-112,038 | -6.19 % | $93,628 | | | | | | News Article | History of Price T Rowe Associates Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rainier Investment Management Inc | Institution | 256,060 | New Holding | 256,060 | 100 % | $10,867,186 | $10,193,749 | $-673,438 | -6.19 % | $-673,438 | | | | | | News Article | History of Rainier Investment Management Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Capital Markets Arbitrage S A | Institution | 1,507 | Sold Some | -727 | -32.54 % | $63,957 | $59,994 | $-3,963 | -6.19 % | $1,912 | | | | | | News Article | History of Rbc Capital Markets Arbitrage S A Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Dain Rauscher Inc | Institution | 2,664 | New Holding | 2,664 | 100 % | $113,060 | $106,054 | $-7,006 | -6.19 % | $-7,006 | | | | | | News Article | History of Rbc Dain Rauscher Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Sg Americas Securities Llc | Institution | 4,636 | Sold Some | -11,313 | -70.93 % | $196,752 | $184,559 | $-12,193 | -6.19 % | $29,753 | | | | | | News Article | History of Sg Americas Securities Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | U S Global Investors Inc | Institution | | Sold All | -2,500 | -100 % | | | | -6.19 % | $6,575 | | | | | | News Article | History of U S Global Investors Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Vanguard Group Inc | Institution | 670,238 | Added More | 15,019 | 2.29 % | $28,444,901 | $26,682,175 | $-1,762,726 | -6.19 % | $-39,500 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Wolverine Asset Management Llc | Institution | 199,711 | New Holding | 199,711 | 100 % | $8,475,735 | $7,950,495 | $-525,240 | -6.19 % | $-525,240 | | | | | | News Article | History of Wolverine Asset Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-12 | 2009-10-30 | 13F-HR | Td Asset Management Inc | Institution | | Sold All | -4,700 | -100 % | | | | -8.27 % | $16,873 | | | | | | News Article | History of Td Asset Management Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Allianz Global Investors Of America L P | Institution | 368,779 | Added More | 259,177 | 236.47 % | $16,005,009 | $14,681,092 | $-1,323,917 | -8.27 % | $-930,445 | | | | | | News Article | History of Allianz Global Investors Of America L P Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Bank Of America Corp | Institution | 481,609 | Sold Some | -23,543 | -4.66 % | $20,901,831 | $19,172,854 | $-1,728,976 | -8.27 % | $84,519 | | | | | | News Article | History of Bank Of America Corp Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 1,019,628 | Added More | 87,278 | 9.36 % | $44,251,855 | $40,591,391 | $-3,660,465 | -8.27 % | $-313,328 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Bbt Capital Management Inc | Institution | 70,000 | Sold Some | -80,000 | -53.33 % | $3,038,000 | $2,786,700 | $-251,300 | -8.27 % | $287,200 | | | | | | News Article | History of Bbt Capital Management Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Columbia Wanger Asset Management Lp | Institution | 826,900 | New Holding | 826,900 | 100 % | $35,887,460 | $32,918,889 | $-2,968,571 | -8.27 % | $-2,968,571 | | | | | | News Article | History of Columbia Wanger Asset Management Lp Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Credit Suisse | Institution | 6,533 | New Holding | 6,533 | 100 % | $283,532 | $260,079 | $-23,453 | -8.27 % | $-23,453 | | | | | | News Article | History of Credit Suisse Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Fortis Investments Management Usa Inc | Institution | 20,159 | No Change | 0 | 0 % | $874,901 | $802,530 | $-72,371 | -8.27 % | $0 | | | | | | News Article | History of Fortis Investments Management Usa Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Ing Investment Management Co | Institution | 102,837 | Added More | 21,715 | 26.76 % | $4,463,126 | $4,093,941 | $-369,185 | -8.27 % | $-77,957 | | | | | | News Article | History of Ing Investment Management Co Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | L S Advisors Inc | Institution | | Sold All | -8,200 | -100 % | | | | -8.27 % | $29,438 | | | | | | News Article | History of L S Advisors Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 173,763 | Added More | 163,041 | 1520.62 % | $7,541,314 | $6,917,505 | $-623,809 | -8.27 % | $-585,317 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Mfc Global Investment Management Usa Ltd | Institution | 15,842 | Added More | 1,462 | 10.16 % | $687,543 | $630,670 | $-56,873 | -8.27 % | $-5,249 | | | | | | News Article | History of Mfc Global Investment Management Usa Ltd Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Ii Inc | Institution | 599 | Added More | 41 | 7.34 % | $25,997 | $23,846 | $-2,150 | -8.27 % | $-147 | | | | | | News Article | History of Padco Advisors Ii Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Inc | Institution | 756 | Added More | 297 | 64.70 % | $32,810 | $30,096 | $-2,714 | -8.27 % | $-1,066 | | | | | | News Article | History of Padco Advisors Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Palisade Capital Management Llc | Institution | 20,800 | Added More | 5,900 | 39.59 % | $902,720 | $828,048 | $-74,672 | -8.27 % | $-21,181 | | | | | | News Article | History of Palisade Capital Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Pier Capital Llc | Institution | 49,691 | New Holding | 49,691 | 100 % | $2,156,589 | $1,978,199 | $-178,391 | -8.27 % | $-178,391 | | | | | | News Article | History of Pier Capital Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Royal Bank Of Scotland Group Plc | Institution | 10,000 | No Change | 0 | 0 % | $434,000 | $398,100 | $-35,900 | -8.27 % | $0 | | | | | | News Article | History of Royal Bank Of Scotland Group Plc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Sovereign Asset Management Corp | Institution | 148,796 | Added More | 25,325 | 20.51 % | $6,457,746 | $5,923,569 | $-534,178 | -8.27 % | $-90,917 | | | | | | News Article | History of Sovereign Asset Management Corp Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Suntrust Banks Inc | Institution | 55,067 | Sold Some | -1,720 | -3.02 % | $2,389,908 | $2,192,217 | $-197,691 | -8.27 % | $6,175 | | | | | | News Article | History of Suntrust Banks Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | 32,460 | Sold Some | -178,602 | -84.62 % | $1,408,764 | $1,292,233 | $-116,531 | -8.27 % | $641,181 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Tewksbury Capital Management Ltd | Institution | | Sold All | -10,715 | -100 % | | | | -8.27 % | $38,467 | | | | | | News Article | History of Tewksbury Capital Management Ltd Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Alphabet Management Llc | No Data | | Sold All | -33,824 | -100 % | | | | -8.10 % | $118,722 | | | | | | News Article | History of Alphabet Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | American Century Companies Inc | Institution | 27,290 | Sold Some | -7,855 | -22.35 % | $1,182,203 | $1,086,415 | $-95,788 | -8.10 % | $27,571 | | | | | | News Article | History of American Century Companies Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Citigroup Inc | Institution | 44,868 | Sold Some | -8,870 | -16.50 % | $1,943,682 | $1,786,195 | $-157,487 | -8.10 % | $31,134 | | | | | | News Article | History of Citigroup Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Glenmede Trust Co Na | Institution | 5,237 | Added More | 26 | 0.49 % | $226,867 | $208,485 | $-18,382 | -8.10 % | $-91 | | | | | | News Article | History of Glenmede Trust Co Na Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ig Investment Management Ltd | Institution | 71,300 | Added More | 28,575 | 66.88 % | $3,088,716 | $2,838,453 | $-250,263 | -8.10 % | $-100,298 | | | | | | News Article | History of Ig Investment Management Ltd Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | J P Morgan Chase And Co | Institution | 203,512 | Added More | 107,410 | 111.76 % | $8,816,140 | $8,101,813 | $-714,327 | -8.10 % | $-377,009 | | | | | | News Article | History of J P Morgan Chase And Co Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Platte River Capital Llc | Institution | 53,000 | New Holding | 53,000 | 100 % | $2,295,960 | $2,109,930 | $-186,030 | -8.10 % | $-186,030 | | | | | | News Article | History of Platte River Capital Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Tesseract Capital Llc | No Data | 100 | New Holding | 100 | 100 % | $4,332 | $3,981 | $-351 | -8.10 % | $-351 | | | | | | News Article | History of Tesseract Capital Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | 215,724 | Added More | 137,108 | 174.40 % | $9,345,164 | $8,587,972 | $-757,191 | -8.10 % | $-481,249 | | | | | | News Article | History of Ubs Ag Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Aberdeen Asset Management Plc | Institution | 9,900 | New Holding | 9,900 | 100 % | $433,719 | $394,119 | $-39,600 | -9.13 % | $-39,600 | | | | | | News Article | History of Aberdeen Asset Management Plc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | N-Q | Forum Funds - Adams Harkness Small Cap Growth Fund | Small-Cap Growth | | Sold All | -3,575 | -100 % | | | | -9.13 % | $14,300 | | | | | | News Article | History of Forum Funds - Adams Harkness Small Cap Growth Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Lee Munder Capital Group Llc | No Data | 85,851 | No Compare | | | $3,761,132 | $3,417,728 | $-343,404 | -9.13 % | | | | | | | News Article | History of Lee Munder Capital Group Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Numeric Investors Llc | Institution | 5,800 | New Holding | 5,800 | 100 % | $254,098 | $230,898 | $-23,200 | -9.13 % | $-23,200 | | | | | | News Article | History of Numeric Investors Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metropolitan Life Insurance Co | Institution | 15,015 | No Change | 0 | 0 % | $672,972 | $597,747 | $-75,225 | -11.17 % | $0 | | | | | | News Article | History of Metropolitan Life Insurance Co Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pioneer Investment Management Inc | Institution | 588,926 | Sold Some | -123,045 | -17.28 % | $26,395,663 | $23,445,144 | $-2,950,519 | -11.17 % | $616,455 | | | | | | News Article | History of Pioneer Investment Management Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pnc Financial Services Group Inc | Institution | | Sold All | -332 | -100 % | | | | -11.17 % | $1,663 | | | | | | News Article | History of Pnc Financial Services Group Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Schwab Charles Investment Management Inc | Institution | 31,000 | No Change | 0 | 0 % | $1,389,420 | $1,234,110 | $-155,310 | -11.17 % | $0 | | | | | | News Article | History of Schwab Charles Investment Management Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Teachers Advisors Inc | Institution | 37,895 | Sold Some | -90 | -0.23 % | $1,698,454 | $1,508,600 | $-189,854 | -11.17 % | $451 | | | | | | News Article | History of Teachers Advisors Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tiaa Cref Investment Management Llc | Institution | 99,100 | Added More | 50 | 0.05 % | $4,441,662 | $3,945,171 | $-496,491 | -11.17 % | $-251 | | | | | | News Article | History of Tiaa Cref Investment Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Trilogy Global Advisors Llc | Institution | | Sold All | -42,500 | -100 % | | | | -11.17 % | $212,925 | | | | | | News Article | History of Trilogy Global Advisors Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Parametric Portfolio Associates | Institution | 4,953 | Added More | 525 | 11.85 % | $210,750 | $197,179 | $-13,571 | -6.43 % | $-1,439 | | | | | | News Article | History of Parametric Portfolio Associates Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Proshare Advisors Llc | Institution | | Sold All | -6,687 | -100 % | | | | -6.43 % | $18,322 | | | | | | News Article | History of Proshare Advisors Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Value Line Inc | Institution | 25,500 | Sold Some | -12,000 | -32.00 % | $1,085,025 | $1,015,155 | $-69,870 | -6.43 % | $32,880 | | | | | | News Article | History of Value Line Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Gw Capital Management Incco | Institution | 9,200 | No Change | 0 | 0 % | $372,968 | $366,252 | $-6,716 | -1.80 % | $0 | | | | | | News Article | History of Gw Capital Management Incco Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | M And T Bank Corp | Institution | | Sold All | -22,225 | -100 % | | | | -5.46 % | $51,118 | | | | | | News Article | History of M And T Bank Corp Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Emerald Advisers Inc | Institution | 123,103 | New Holding | 123,103 | 100 % | $4,901,961 | $4,900,730 | $-1,231 | -0.02 % | $-1,231 | | | | | | News Article | History of Emerald Advisers Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Emerald Mutual Fund Advisers Trust | Institution | 52,490 | New Holding | 52,490 | 100 % | $2,090,152 | $2,089,627 | $-525 | -0.02 % | $-525 | | | | | | News Article | History of Emerald Mutual Fund Advisers Trust Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | First New York Securities Llc | Institution | | Sold All | -10,000 | -100 % | | | | -0.02 % | $100 | | | | | | News Article | History of First New York Securities Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Health Care Portfolio | Health/Biotech | | Sold All | -78,664 | -100 % | | | | -0.02 % | $787 | | | | | | News Article | History of Fidelity Select Portfolios - Health Care Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Pharmaceuticals Portfolio | Health/Biotech | 1,200 | Sold Some | -2,800 | -70.00 % | $47,784 | $47,772 | $-12 | -0.02 % | $28 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Technology Portfolio | Science & Tech | | Sold All | -151,100 | -100 % | | | | -0.02 % | $1,511 | | | | | | News Article | History of Fidelity Select Portfolios - Technology Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Oxford Asset Management | Institution | | Sold All | -7,650 | -100 % | | | | 5.37 % | $-15,530 | | | | | | News Article | History of Oxford Asset Management Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Windward Investment Management Inc | Institution | 10,000 | No Change | 0 | 0 % | $377,800 | $398,100 | $20,300 | 5.37 % | $0 | | | | | | News Article | History of Windward Investment Management Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Advisor Series I - Large Cap Fund | Large-Cap Core | | Sold All | -103,756 | -100 % | | | | 5.37 % | $-210,625 | | | | | | News Article | History of Fidelity Advisor Series I - Large Cap Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock | Specialty & Misc | 736 | No Compare | | | $27,806 | $29,300 | $1,494 | 5.37 % | | | | | | | News Article | History of Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Mt Vernon Street Trust - Fidelity Aggressive Growth Fund | Multi-Cap Growth | 351,936 | Sold Some | -1,208,992 | -77.45 % | $13,296,142 | $14,010,572 | $714,430 | 5.37 % | $-2,454,254 | | | | | | News Article | History of Fidelity Mt Vernon Street Trust - Fidelity Aggressive Growth Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Securities Fund - Agressive Growth Fund | Global Small/Mid-Cap Growth | 5,417 | New Holding | 5,417 | 100 % | $204,654 | $215,651 | $10,997 | 5.37 % | $10,997 | | | | | | News Article | History of Fidelity Securities Fund - Agressive Growth Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Jennison Sector Funds Inc - Jennison Health Sciences Fund | Health/Biotech | 577,400 | No Change | 0 | 0 % | $21,814,172 | $22,986,294 | $1,172,122 | 5.37 % | $0 | | | | | | News Article | History of Jennison Sector Funds Inc - Jennison Health Sciences Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-CSR | Vanguard World Fund - Vanguard Health Care Index Fund | Health/Biotech | 7,761 | Sold Some | -291 | -3.61 % | $293,211 | $308,965 | $15,755 | 5.37 % | $-591 | | | | | | News Article | History of Vanguard World Fund - Vanguard Health Care Index Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 272,228 | Sold Some | -1,900 | -0.69 % | $10,431,777 | $10,837,397 | $405,620 | 3.88 % | $-2,831 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Health Sciences Fund | Health/Biotech | 600 | New Holding | 600 | 100 % | $22,992 | $23,886 | $894 | 3.88 % | $894 | | | | | | News Article | History of Valic Co I - Health Sciences Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Small Cap Index Fund | Small-Cap Core | 13,784 | New Holding | 13,784 | 100 % | $528,203 | $548,741 | $20,538 | 3.88 % | $20,538 | | | | | | News Article | History of Valic Co I - Small Cap Index Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Value Fund | Multi-Cap Value | 18,517 | New Holding | 18,517 | 100 % | $709,571 | $737,162 | $27,590 | 3.88 % | $27,590 | | | | | | News Article | History of Valic Co I - Value Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-28 | 2009-08-31 | N-Q | Dws Securities Trust - Dws Health Care Fund | Health/Biotech | 16,600 | New Holding | 16,600 | 100 % | $570,210 | $660,846 | $90,636 | 15.89 % | $90,636 | | | | | | News Article | History of Dws Securities Trust - Dws Health Care Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Essex Investment Management Co Llc | Institution | 1,295 | No Change | 0 | 0 % | $45,053 | $51,554 | $6,501 | 14.42 % | $0 | | | | | | News Article | History of Essex Investment Management Co Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Sterling Johnston Capital Management Lp | Institution | | Sold All | -44,800 | -100 % | | | | 14.42 % | $-224,896 | | | | | | News Article | History of Sterling Johnston Capital Management Lp Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Claymore Exchange Traded Fund Trust - Claymoremorningstar Services Super Sector Index Etf | Specialty & Misc | 9 | No Change | 0 | 0 % | $309 | $358 | $49 | 15.96 % | $0 | | | | | | News Article | History of Claymore Exchange Traded Fund Trust - Claymoremorningstar Services Super Sector Index Etf Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-26 | 2009-06-30 | 13F-HR/A | Ameriprise Financial Inc | Institution | 615 | Added More | 590 | 2360.00 % | $21,113 | $24,483 | $3,370 | 15.96 % | $3,233 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Advisors Llc | Institution | 203,200 | New Holding | 203,200 | 100 % | $7,463,536 | $8,089,392 | $625,856 | 8.38 % | $625,856 | | | | | | News Article | History of Blackrock Advisors Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Group Ltd | Institution | 5,300 | No Change | 0 | 0 % | $194,669 | $210,993 | $16,324 | 8.38 % | $0 | | | | | | News Article | History of Blackrock Group Ltd Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Inc | No Data | 21,900 | Added More | 15,099 | 222.01 % | $804,387 | $871,839 | $67,452 | 8.38 % | $46,505 | | | | | | News Article | History of Blackrock Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Investment Management Llc | Institution | 60,588 | Added More | 20,172 | 49.91 % | $2,225,397 | $2,412,008 | $186,611 | 8.38 % | $62,130 | | | | | | News Article | History of Blackrock Investment Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Merrill Lynch Mercury Asset Management Japan Ltd | Institution | 1,400 | New Holding | 1,400 | 100 % | $51,422 | $55,734 | $4,312 | 8.38 % | $4,312 | | | | | | News Article | History of Merrill Lynch Mercury Asset Management Japan Ltd Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 77,459 | Sold Some | -5,979 | -7.16 % | $2,797,819 | $3,083,643 | $285,824 | 10.21 % | $-22,063 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | State Board Of Administration Of Florida Retirement System | Institution | 33,550 | Added More | 11,377 | 51.31 % | $1,211,826 | $1,335,626 | $123,800 | 10.21 % | $41,981 | | | | | | News Article | History of State Board Of Administration Of Florida Retirement System Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Public Employees Retirement Association Of Colorado | Institution | 34,800 | No Change | 0 | 0 % | $1,253,496 | $1,385,388 | $131,892 | 10.52 % | $0 | | | | | | News Article | History of Public Employees Retirement Association Of Colorado Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Weisel Thomas Partners Asset Management Llc | Institution | | Sold All | -2,160 | -100 % | | | | 10.52 % | $-8,186 | | | | | | News Article | History of Weisel Thomas Partners Asset Management Llc Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Hanseatic Management Services Inc | Institution | | Sold All | -4,090 | -100 % | | | | 10.86 % | $-15,951 | | | | | | News Article | History of Hanseatic Management Services Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Strs Ohio | Institution | 29,300 | Sold Some | -2,800 | -8.72 % | $1,052,163 | $1,166,433 | $114,270 | 10.86 % | $-10,920 | | | | | | News Article | History of Strs Ohio Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Public Employees Retirement System Of Ohio | Institution | 20,869 | No Change | 0 | 0 % | $749,614 | $830,795 | $81,180 | 10.82 % | $0 | | | | | | News Article | History of Public Employees Retirement System Of Ohio Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR/A | Standard Life Investments | Institution | 748,165 | No Change | 0 | 0 % | $26,874,087 | $29,784,449 | $2,910,362 | 10.82 % | $0 | | | | | | News Article | History of Standard Life Investments Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR/A | Standard Life Investments | Institution | 963,173 | Added More | 215,008 | 28.73 % | $34,597,174 | $38,343,917 | $3,746,743 | 10.82 % | $836,381 | | | | | | News Article | History of Standard Life Investments Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-13 | 2009-09-30 | 13F-HR | Financial Architects Inc | Institution | | Sold All | -500 | -100 % | | | | 11.01 % | $-1,975 | | | | | | News Article | History of Financial Architects Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-08 | 2009-09-30 | 13F-HR | Rhumbline Advisers | Institution | 24,763 | Sold Some | -500 | -1.97 % | $915,240 | $985,815 | $70,575 | 7.71 % | $-1,425 | | | | | | News Article | History of Rhumbline Advisers Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund | Health/Biotech | | Sold All | -6,600 | -100 % | | | | 2.07 % | $-5,346 | | | | | | News Article | History of Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Fidelity Advisor Series Vii - Fidelity Advisor Health Care Fund | Health/Biotech | | Sold All | -27,927 | -100 % | | | | 2.07 % | $-22,621 | | | | | | News Article | History of Fidelity Advisor Series Vii - Fidelity Advisor Health Care Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Profunds - Bull Profund | Large-Cap Core | 636 | Added More | 315 | 98.13 % | $24,804 | $25,319 | $515 | 2.07 % | $255 | | | | | | News Article | History of Profunds - Bull Profund Ownership Of Amag Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Alliancebernstein Cap Fund Inc - Alliancebernstein Small Cap Growth Portfolio | Small-Cap Growth | 61,600 | Added More | 40,900 | 197.58 % | $2,534,224 | $2,452,296 | $-81,928 | -3.23 % | $-54,397 | | | | | | News Article | History of Alliancebernstein Cap Fund Inc - Alliancebernstein Small Cap Growth Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Aim Investment Funds - Aim Developing Markets Fund | Emerging Markets | 125,518 | New Holding | 125,518 | 100 % | $5,667,138 | $4,996,872 | $-670,266 | -11.82 % | $-670,266 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | American Century Mutual Funds Inc - New Opportunities Fund | Small-Cap Growth | 6,938 | Sold Some | -5,553 | -44.45 % | $313,251 | $276,202 | $-37,049 | -11.82 % | $29,653 | | | | | | News Article | History of American Century Mutual Funds Inc - New Opportunities Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | American Century Mutual Funds Inc - New Opportunities Ii | Small-Cap Growth | 24,240 | Sold Some | -22,479 | -48.11 % | $1,094,436 | $964,994 | $-129,442 | -11.82 % | $120,038 | | | | | | News Article | History of American Century Mutual Funds Inc - New Opportunities Ii Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Core Equity Portfolio | International Small-Mid-Cap Value | 28,748 | New Holding | 28,748 | 100 % | $1,297,972 | $1,144,458 | $-153,514 | -11.82 % | $-153,514 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Core Equity Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio | No Data | 1,450 | New Holding | 1,450 | 100 % | $65,468 | $57,725 | $-7,743 | -11.82 % | $-7,743 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio | No Data | 200 | New Holding | 200 | 100 % | $9,030 | $7,962 | $-1,068 | -11.82 % | $-1,068 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dunham Funds - Dunham Small Cap Growth Fund | No Data | 1,571 | New Holding | 1,571 | 100 % | $70,931 | $62,542 | $-8,389 | -11.82 % | $-8,389 | | | | | | News Article | History of Dunham Funds - Dunham Small Cap Growth Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Evergreen Equity Trust De - Evergreen Health Care Fund | Health/Biotech | 66,755 | New Holding | 66,755 | 100 % | $3,013,988 | $2,657,517 | $-356,472 | -11.82 % | $-356,472 | | | | | | News Article | History of Evergreen Equity Trust De - Evergreen Health Care Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Fidelity Commonwealth Trust - Fidelity Large Cap Stock Fund | Large-Cap Core | | Sold All | -59,230 | -100 % | | | | -11.82 % | $316,288 | | | | | | News Article | History of Fidelity Commonwealth Trust - Fidelity Large Cap Stock Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Ishares Trust - Ishares Morningstar Small Growth Index Fund | Small-Cap Growth | 5,646 | Added More | 972 | 20.79 % | $254,917 | $224,767 | $-30,150 | -11.82 % | $-5,190 | | | | | | News Article | History of Ishares Trust - Ishares Morningstar Small Growth Index Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Janus Investment Fund - Janus Fund | Large-Cap Growth | 163,547 | New Holding | 163,547 | 100 % | $7,384,147 | $6,510,806 | $-873,341 | -11.82 % | $-873,341 | | | | | | News Article | History of Janus Investment Fund - Janus Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Jnl Investors Series Trust - Jackson Perspective Index 5 Fund | Specialty & Misc | 131 | No Change | 0 | 0 % | $5,915 | $5,215 | $-700 | -11.82 % | $0 | | | | | | News Article | History of Jnl Investors Series Trust - Jackson Perspective Index 5 Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Seligman Frontier Fund Inc - Seligman Frontier Fund Inc | Small-Cap Growth | 2,500 | New Holding | 2,500 | 100 % | $112,875 | $99,525 | $-13,350 | -11.82 % | $-13,350 | | | | | | News Article | History of Seligman Frontier Fund Inc - Seligman Frontier Fund Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Fbr Funds - Fbr Small Cap Fund | Small-Cap Growth | 700 | New Holding | 700 | 100 % | $31,955 | $27,867 | $-4,088 | -12.79 % | $-4,088 | | | | | | News Article | History of Fbr Funds - Fbr Small Cap Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund | Small-Cap Core | 3,160 | Added More | 2,990 | 1758.82 % | $144,254 | $125,800 | $-18,454 | -12.79 % | $-17,462 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund | Small-Cap Core | 6,400 | Added More | 6,100 | 2033.33 % | $292,160 | $254,784 | $-37,376 | -12.79 % | $-35,624 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Old Westbury Funds Inc - International Fund | International Multi-Cap Core | 2,700 | No Change | 0 | 0 % | $123,255 | $107,487 | $-15,768 | -12.79 % | $0 | | | | | | News Article | History of Old Westbury Funds Inc - International Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange Traded Fund Trust - Powershares Dynamic Small Cap Growth Portfolio | Small-Cap Growth | 284 | New Holding | 284 | 100 % | $12,965 | $11,306 | $-1,659 | -12.79 % | $-1,659 | | | | | | News Article | History of Powershares Exchange Traded Fund Trust - Powershares Dynamic Small Cap Growth Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Direxion Shares Etf Trust - Direxion Daily Small Cap Bull 3x Shares | No Data | 6,249 | New Holding | 6,249 | 100 % | $277,393 | $248,773 | $-28,620 | -10.31 % | $-28,620 | | | | | | News Article | History of Direxion Shares Etf Trust - Direxion Daily Small Cap Bull 3x Shares Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Mtb Group Of Funds - Mtb Multi Cap Growth Fund | Multi-Cap Core | 475 | New Holding | 475 | 100 % | $21,085 | $18,910 | $-2,176 | -10.31 % | $-2,176 | | | | | | News Article | History of Mtb Group Of Funds - Mtb Multi Cap Growth Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Mtb Group Of Funds - Mtb Small Cap Growth Fund | Small-Cap Growth | 23,900 | Added More | 4,900 | 25.78 % | $1,060,921 | $951,459 | $-109,462 | -10.31 % | $-22,442 | | | | | | News Article | History of Mtb Group Of Funds - Mtb Small Cap Growth Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-25 | 2009-03-31 | N-Q/A | Hirtle Callaghan Trust - The Small Capitalization Equity Portfolio | Small-Cap Core | 8,600 | Added More | 3,328 | 63.12 % | $381,754 | $342,366 | $-39,388 | -10.31 % | $-15,242 | | | | | | News Article | History of Hirtle Callaghan Trust - The Small Capitalization Equity Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-24 | 2009-06-30 | 13F-HR/A | Credit Agricole S A | Institution | 4,893 | New Holding | 4,893 | 100 % | $219,353 | $194,790 | $-24,563 | -11.19 % | $-24,563 | | | | | | News Article | History of Credit Agricole S A Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-22 | 2009-07-31 | N-Q | Dreyfus Premier Opportunity Funds - Health Care Fund | Health/Biotech | 4,530 | New Holding | 4,530 | 100 % | $214,133 | $180,339 | $-33,794 | -15.78 % | $-33,794 | | | | | | News Article | History of Dreyfus Premier Opportunity Funds - Health Care Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-17 | 2009-07-31 | N-Q | Rydex Etf Trust - Rydex Inverse Russell 2000 Etf | Specialty & Misc | 360 | New Holding | 360 | 100 % | $15,826 | $14,332 | $-1,494 | -9.44 % | $-1,494 | | | | | | News Article | History of Rydex Etf Trust - Rydex Inverse Russell 2000 Etf Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-15 | 2009-06-30 | N-CSRS/A | Wilshire Mutual Funds Inc - Wilshire Small Company Growth Portfolio | Small-Cap Growth | 125 | No Change | 0 | 0 % | $5,010 | $4,976 | $-34 | -0.67 % | $0 | | | | | | News Article | History of Wilshire Mutual Funds Inc - Wilshire Small Company Growth Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 932,350 | Sold Some | -7,005 | -0.74 % | $37,461,823 | $37,116,854 | $-344,970 | -0.92 % | $2,592 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Allianz Variable Insurance Products Trust - Azl Occ Opportunity Fund | Specialty & Misc | 21,130 | Sold Some | -7,545 | -26.31 % | $909,858 | $841,185 | $-68,673 | -7.54 % | $24,521 | | | | | | News Article | History of Allianz Variable Insurance Products Trust - Azl Occ Opportunity Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Professionally Managed Portfolios - Winslow Green Growth Fund | No Data | 200,000 | Added More | 27,013 | 15.61 % | $8,612,000 | $7,962,000 | $-650,000 | -7.54 % | $-87,792 | | | | | | News Article | History of Professionally Managed Portfolios - Winslow Green Growth Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Series Funds - Banking Fund | Financial Services | 459 | Sold Some | -80 | -14.84 % | $19,765 | $18,273 | $-1,492 | -7.54 % | $260 | | | | | | News Article | History of Rydex Series Funds - Banking Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Variable Trust - Biotechnology Fund | Health/Biotech | 218 | Added More | 80 | 57.97 % | $9,387 | $8,679 | $-709 | -7.54 % | $-260 | | | | | | News Article | History of Rydex Variable Trust - Biotechnology Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio | Small-Cap Growth | 9,400 | Sold Some | -7,700 | -45.02 % | $403,260 | $374,214 | $-29,046 | -7.20 % | $23,793 | | | | | | News Article | History of Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio | Small-Cap Growth | 92,753 | Added More | 49,300 | 113.45 % | $3,979,104 | $3,692,497 | $-286,607 | -7.20 % | $-152,337 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Value Portfolio | Multi-Cap Value | 3,070 | New Holding | 3,070 | 100 % | $131,703 | $122,217 | $-9,486 | -7.20 % | $-9,486 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Value Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqbond Index Portfolio | Specialty & Misc | 25,592 | Added More | 1,740 | 7.29 % | $1,097,897 | $1,018,818 | $-79,079 | -7.20 % | $-5,377 | | | | | | News Article | History of Eq Advisors Trust - Eqbond Index Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I - Jpmorgan Small Cap Core Fund | Small-Cap Core | 1 | New Holding | 1 | 100 % | $43 | $40 | $-3 | -7.20 % | $-3 | | | | | | News Article | History of Jpmorgan Trust I - Jpmorgan Small Cap Core Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust Ii - Jpmorgan Core Bond Fund | Multi-Cap Core | 1 | New Holding | 1 | 100 % | $43 | $40 | $-3 | -7.20 % | $-3 | | | | | | News Article | History of Jpmorgan Trust Ii - Jpmorgan Core Bond Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds - Bull Profund | Large-Cap Core | 321 | Sold Some | -525 | -62.05 % | $13,771 | $12,779 | $-992 | -7.20 % | $1,622 | | | | | | News Article | History of Profunds - Bull Profund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Sun Capital Advisers Trust - Sc Aim Small Cap Growth Fund | No Data | 2,769 | Added More | 1,301 | 88.62 % | $118,790 | $110,234 | $-8,556 | -7.20 % | $-4,020 | | | | | | News Article | History of Sun Capital Advisers Trust - Sc Aim Small Cap Growth Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund | Small-Cap Core | 250 | Sold Some | -50 | -16.66 % | $10,725 | $9,953 | $-773 | -7.20 % | $155 | | | | | | News Article | History of Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Institutional Index Funds - Vanguard Institutional Index Fund | Specialty & Misc | 15,601 | New Holding | 15,601 | 100 % | $669,283 | $621,076 | $-48,207 | -7.20 % | $-48,207 | | | | | | News Article | History of Vanguard Institutional Index Funds - Vanguard Institutional Index Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-10 | N-CSRS | Jpmorgan Insurance Trust - Jpmorgan Insurance Trust Balanced Portfolio | Flexible Portfolio | 100 | New Holding | 100 | 100 % | $4,290 | $3,981 | $-309 | -7.20 % | $-309 | | | | | | News Article | History of Jpmorgan Insurance Trust - Jpmorgan Insurance Trust Balanced Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund Ii - Mml Small Cap Equity Fund | Small-Cap Core | 220 | Added More | 20 | 10.00 % | $9,405 | $8,758 | $-647 | -6.87 % | $-59 | | | | | | News Article | History of Mml Series Investment Fund Ii - Mml Small Cap Equity Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Pd Small-Cap Growth Index Portfolio | No Data | 293 | No Compare | | | $12,526 | $11,664 | $-861 | -6.87 % | | | | | | | News Article | History of Pacific Select Fund - Pd Small-Cap Growth Index Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Small-Cap Index Portfolio | No Data | 8,990 | Sold Some | -200 | -2.17 % | $384,323 | $357,892 | $-26,431 | -6.87 % | $588 | | | | | | News Article | History of Pacific Select Fund - Small-Cap Index Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSR | Streettracks Series Trust - Spdr Dividend Etf | Specialty & Misc | | Sold All | -629 | -100 % | | | | -6.87 % | $1,849 | | | | | | News Article | History of Streettracks Series Trust - Spdr Dividend Etf Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-02 | 2009-06-30 | N-CSR/A | Hirtle Callaghan Trust - The Small Capitalization Equity Portfolio | Small-Cap Core | 8,850 | Added More | 250 | 2.90 % | $370,727 | $352,319 | $-18,408 | -4.96 % | $-520 | | | | | | News Article | History of Hirtle Callaghan Trust - The Small Capitalization Equity Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Met Investors Series Trust - Metaim Small Cap Growth Portfolio | Small-Cap Growth | 149,749 | Added More | 30,081 | 25.13 % | $6,272,986 | $5,961,508 | $-311,478 | -4.96 % | $-62,568 | | | | | | News Article | History of Met Investors Series Trust - Metaim Small Cap Growth Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Amvescap Plc | Institution | 586,608 | Sold Some | -534,456 | -47.67 % | $24,086,124 | $23,352,864 | $-733,260 | -3.04 % | $668,070 | | | | | | News Article | History of Amvescap Plc Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Fidelity International Ltd | Institution | 650 | New Holding | 650 | 100 % | $26,689 | $25,877 | $-813 | -3.04 % | $-813 | | | | | | News Article | History of Fidelity International Ltd Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Fmr Corp | Institution | 1,124,848 | Sold Some | -1,427,552 | -55.92 % | $46,186,259 | $44,780,199 | $-1,406,060 | -3.04 % | $1,784,440 | | | | | | News Article | History of Fmr Corp Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | N-CSRS | Neuberger Berman Advisers Management Trust - Balanced Portfolio | Flexible Portfolio | 500 | New Holding | 500 | 100 % | $20,530 | $19,905 | $-625 | -3.04 % | $-625 | | | | | | News Article | History of Neuberger Berman Advisers Management Trust - Balanced Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | N-CSRS | Neuberger Berman Advisers Management Trust - Growth Portfolio | Multi-Cap Growth | 33,900 | New Holding | 33,900 | 100 % | $1,391,934 | $1,349,559 | $-42,375 | -3.04 % | $-42,375 | | | | | | News Article | History of Neuberger Berman Advisers Management Trust - Growth Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Fidelity Central Investment Portfolios Llc - Fidelity Health Care | Health/Biotech | 30,407 | Sold Some | -18,410 | -37.71 % | $1,247,903 | $1,210,503 | $-37,401 | -2.99 % | $22,644 | | | | | | News Article | History of Fidelity Central Investment Portfolios Llc - Fidelity Health Care Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Northern Lights Fund Trust - Biondo Fund | Health/Biotech | | Sold All | -150 | -100 % | | | | -2.99 % | $185 | | | | | | News Article | History of Northern Lights Fund Trust - Biondo Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Tiaa Cref Life Fund - Stock Index Fund | Specialty & Misc | 205 | Added More | 48 | 30.57 % | $8,413 | $8,161 | $-252 | -2.99 % | $-59 | | | | | | News Article | History of Tiaa Cref Life Fund - Stock Index Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSR | Allianz Funds - Occ Value | Large-Cap Value | 34,173 | Sold Some | -12,702 | -27.09 % | $1,413,737 | $1,360,427 | $-53,310 | -3.77 % | $19,815 | | | | | | News Article | History of Allianz Funds - Occ Value Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Columbia Funds Variable Insurance Trust - Columbia Asset Allocation Fund Variable Series | Specialty & Misc | 110 | New Holding | 110 | 100 % | $4,551 | $4,379 | $-172 | -3.77 % | $-172 | | | | | | News Article | History of Columbia Funds Variable Insurance Trust - Columbia Asset Allocation Fund Variable Series Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Columbia Funds Variable Insurance Trust - Columbia Small Company Growth Fund Variable Series | Small-Cap Growth | 1,930 | New Holding | 1,930 | 100 % | $79,844 | $76,833 | $-3,011 | -3.77 % | $-3,011 | | | | | | News Article | History of Columbia Funds Variable Insurance Trust - Columbia Small Company Growth Fund Variable Series Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Evergreen Equity Trust De - Evergreen Aggressive Growth Fund | Multi-Cap Growth | 20,300 | Sold Some | -2,900 | -12.50 % | $839,811 | $808,143 | $-31,668 | -3.77 % | $4,524 | | | | | | News Article | History of Evergreen Equity Trust De - Evergreen Aggressive Growth Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Evergreen Equity Trust De - Evergreen Omega Fund | Specialty & Misc | | Sold All | -11,700 | -100 % | | | | -3.77 % | $18,252 | | | | | | News Article | History of Evergreen Equity Trust De - Evergreen Omega Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Nasdaq Biotechnology Index Fund | Health/Biotech | 154,079 | Sold Some | -8,669 | -5.32 % | $6,374,248 | $6,133,885 | $-240,363 | -3.77 % | $13,524 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Growth Index Fund | Multi-Cap Growth | 120,571 | Added More | 5,185 | 4.49 % | $4,988,022 | $4,799,932 | $-188,091 | -3.77 % | $-8,089 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Growth Index Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Index Fund | Specialty & Misc | 205,366 | Sold Some | -4,848 | -2.30 % | $8,495,991 | $8,175,620 | $-320,371 | -3.77 % | $7,563 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Index Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Growth Index Fund | Multi-Cap Growth | 1,031 | Sold Some | -126 | -10.89 % | $42,652 | $41,044 | $-1,608 | -3.77 % | $197 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Growth Index Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Index Fund | Specialty & Misc | 5,111 | Added More | 300 | 6.23 % | $211,442 | $203,469 | $-7,973 | -3.77 % | $-468 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Index Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Smallcap World Fund Inc - Smallcap World Fund Inc | Small-Cap Core | 400,000 | Added More | 100,000 | 33.33 % | $16,548,000 | $15,924,000 | $-624,000 | -3.77 % | $-156,000 | | | | | | News Article | History of Smallcap World Fund Inc - Smallcap World Fund Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Sti Classic Funds - Small Cap Growth Stock Fund | Small-Cap Growth | 41,323 | Added More | 12,539 | 43.56 % | $1,709,533 | $1,645,069 | $-64,464 | -3.77 % | $-19,561 | | | | | | News Article | History of Sti Classic Funds - Small Cap Growth Stock Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Value Line Emerging Opportunities Fund Inc - Value Line Emerging Opportunities Fund Inc | Small-Cap Growth | 37,500 | No Change | 0 | 0 % | $1,551,375 | $1,492,875 | $-58,500 | -3.77 % | $0 | | | | | | News Article | History of Value Line Emerging Opportunities Fund Inc - Value Line Emerging Opportunities Fund Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | 13F-HR/A | Wells Fargo And Co | Institution | 221,043 | Sold Some | -45,343 | -17.02 % | $9,144,549 | $8,799,722 | $-344,827 | -3.77 % | $70,735 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Janus Aspen Series - Global Life Sciences Portfolio | Science & Tech | 4,197 | Sold Some | -1,978 | -32.03 % | $174,889 | $167,083 | $-7,806 | -4.46 % | $3,679 | | | | | | News Article | History of Janus Aspen Series - Global Life Sciences Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Equity Index Fund | Specialty & Misc | 11,504 | Added More | 7,294 | 173.25 % | $479,372 | $457,974 | $-21,397 | -4.46 % | $-13,567 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Equity Index Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Growth Equity Fund | Multi-Cap Growth | | Sold All | -6,102 | -100 % | | | | -4.46 % | $11,350 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Growth Equity Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Extended Market Index Fund | Mid-Cap Core | 103,697 | New Holding | 103,697 | 100 % | $4,321,054 | $4,128,178 | $-192,876 | -4.46 % | $-192,876 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Extended Market Index Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Growth Index Fund | Large-Cap Growth | 46,030 | New Holding | 46,030 | 100 % | $1,918,070 | $1,832,454 | $-85,616 | -4.46 % | $-85,616 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Growth Index Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Total Stock Market Index Fund | Multi-Cap Core | 157,431 | New Holding | 157,431 | 100 % | $6,560,150 | $6,267,328 | $-292,822 | -4.46 % | $-292,822 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Total Stock Market Index Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Value Index Fund | Large-Cap Value | 87,416 | New Holding | 87,416 | 100 % | $3,642,625 | $3,480,031 | $-162,594 | -4.46 % | $-162,594 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Value Index Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 8,033 | Added More | 1,600 | 24.87 % | $334,735 | $319,794 | $-14,941 | -4.46 % | $-2,976 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 6,433 | No Change | 0 | 0 % | $268,063 | $256,098 | $-11,965 | -4.46 % | $0 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-26 | 2009-06-30 | 13F-HR/A | Duquesne Capital Management L L C | Institution | | Sold All | -475,000 | -100 % | | | | -5.84 % | $1,173,250 | | | | | | News Article | History of Duquesne Capital Management L L C Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | N-CSRS | Forum Funds - Adams Harkness Small Cap Growth Fund | Small-Cap Growth | 3,575 | New Holding | 3,575 | 100 % | $151,973 | $142,321 | $-9,653 | -6.35 % | $-9,653 | | | | | | News Article | History of Forum Funds - Adams Harkness Small Cap Growth Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | 13F-HR/A | Jefferies Group Inc | Institution | 7,700 | New Holding | 7,700 | 100 % | $327,327 | $306,537 | $-20,790 | -6.35 % | $-20,790 | | | | | | News Article | History of Jefferies Group Inc Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | N-CSRS | Maxim Series Fund Inc - Maxim Small-Cap Growth Portfolio | No Data | 9,200 | Added More | 3,500 | 61.40 % | $391,092 | $366,252 | $-24,840 | -6.35 % | $-9,450 | | | | | | News Article | History of Maxim Series Fund Inc - Maxim Small-Cap Growth Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-24 | 2009-06-30 | N-CSRS | Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva | Specialty & Misc | 1,500 | New Holding | 1,500 | 100 % | $63,075 | $59,715 | $-3,360 | -5.32 % | $-3,360 | | | | | | News Article | History of Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-21 | 2009-06-30 | N-CSR | Oppenheimer Main Street Small Cap Fund - Oppenheimer Main Street Small Cap Fund | Small-Cap Core | 6,200 | New Holding | 6,200 | 100 % | $261,826 | $246,822 | $-15,004 | -5.73 % | $-15,004 | | | | | | News Article | History of Oppenheimer Main Street Small Cap Fund - Oppenheimer Main Street Small Cap Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-21 | 2009-06-30 | 13F-HR/A | Sac Capital Advisors Lp | No Data | 410,000 | Added More | 160,000 | 64.00 % | $17,314,300 | $16,322,100 | $-992,200 | -5.73 % | $-387,200 | | | | | | News Article | History of Sac Capital Advisors Lp Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-21 | 2009-06-30 | N-CSRS | Variable Insurance Products Fund Iv - Health Care Portfolio | Health/Biotech | 2,800 | Sold Some | -2,100 | -42.85 % | $118,244 | $111,468 | $-6,776 | -5.73 % | $5,082 | | | | | | News Article | History of Variable Insurance Products Fund Iv - Health Care Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-20 | 2009-06-30 | 13F-HR/A | Driehaus Capital Management Llc | Institution | 60,276 | New Holding | 60,276 | 100 % | $2,539,428 | $2,399,588 | $-139,840 | -5.50 % | $-139,840 | | | | | | News Article | History of Driehaus Capital Management Llc Ownership Of Amag Pharmaceuticals Inc |